Hero image

Research

We run to, not from, the world’s biggest health challenges.

The journey to invention and discovery is guided by science – and inspired by patients

Our purpose is to save and improve lives for generations. Our strategy is simple: We follow the science. The path to discovery is often unclear, but we are tireless in seeking solutions for some of the world’s most difficult health challenges.

Our work in numbers

15.6K

people employed in research and development

357M

people reached through our major programs and partnerships

$9.9B

invested in R&D in 2019

We address the world’s most difficult health challenges, following world-class science

Hero_RGB_Discovery-Blue
Discovery & development

Step inside MSD Research Laboratories (MRL) where our quest to save and improve lives through research and development begins

B5 - Our pipeline__
Pipeline

We’re focused on inventing new medicines and vaccines to help more people

Father playing with young son at breakfast table

Our commitment to patients is unwavering

As long as there are still patients in hospitals, doctors and nurses desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here, fighting with all we have to deliver more, sooner.

Invention begins here

Our scientists are applying the latest groundbreaking research technologies and revolutionizing how we discover and develop medicines and vaccines

View our stories

Experts meet to discuss health care innovations during COVID

MSD’s chief patient officer, Julie Gerberding, joins the Fortune Global Forum to discuss breakthrough innovations in health care

More from Julie

Next: Experts meet to discuss health care innovations during COVID

MSD scientists probe how our bodies’ bugs impact immunity and disease

Our researchers are pioneering new ways to research and understand the biology of new diseases by looking inside the human gut

Read more

Next: MSD scientists probe how our bodies’ bugs impact immunity and disease

Our third-quarter 2020 financial results

MSD announced third-quarter worldwide sales of $12.6 billion – an increase of 1% compared with the third quarter of 2019. Excluding the impact from foreign exchange, sales grew 2%. The company anticipates full-year 2020 revenue range to be between $47.6 billion and $48.6 billion, including a negative impact from foreign exchange of approximately 1.5%. Take […]

Read more

Next: Our third-quarter 2020 financial results

Our new London Discovery Research Centre site

The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter”

Read more

Next: Our new London Discovery Research Centre site

2Q 2020 Financial results

MSD announced second-quarter worldwide sales of $10.9 billion – a decrease of 8% compared with the second quarter of 2019 – reflecting the negative impact of COVID-19. Excluding the impact from foreign exchange, sales declined 5%. ​ The company anticipates full-year 2020 revenue range to be between $47.2 billion and $48.7 billion, including a negative […]

Read more

Next: 2Q 2020 Financial results

Previous
Next